Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

375.94
+11.363.12%
Pre-market: 392.8916.95+4.51%05:34 EDT
Volume:413.32K
Turnover:156.34M
Market Cap:10.47B
PE:-29.23
High:387.99
Open:370.35
Low:365.37
Close:364.58
52wk High:392.70
52wk Low:37.19
Shares:27.85M
Float Shares:24.08M
Volume Ratio:1.02
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:7.81
PE(LYR):-27.90

Loading ...

Praxis Precision Medicine Q2 EPS $(2.87) Beats $(3.65) Estimate

Benzinga Earnings
·
Aug 06

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 EPS USD -2.87

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 Operating Expenses USD 96.904 Million

THOMSON REUTERS
·
Aug 06

Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan

Reuters
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 05

Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview

Reuters
·
Aug 04

Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play

TIPRANKS
·
Aug 04

Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study

TIPRANKS
·
Aug 04

Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG

Dow Jones
·
Jul 29

Praxis Precision Medicines (PRAX) Has a New Rating from Goldman Sachs

TIPRANKS
·
Jul 21

Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach

Simply Wall St.
·
Jul 20

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)

TIPRANKS
·
Jul 13

Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target

MT Newswires Live
·
Jul 13

S&P 500 Futures Decline in Premarket Trading; SK Hynix ADR, MKS Lag

Dow Jones
·
Jul 13

Praxis Precision Med Initiated at Buy by Goldman Sachs

Dow Jones
·
Jul 13

Praxis Precision initiated with a Buy at Goldman Sachs

TIPRANKS
·
Jul 13

RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 11